Cardiotocograph (CTG) Market REPORT OVERVIEW
- Request a Free sample to learn more about this report
The global cardiotocograph (CTG) market size was USD 330.6 million 2021 and is projected to touch USD 537.83 million by 2031, at a CAGR of 5.0% during the forecast period.
Cardiotocography is commonly referred to as a "CTG" by physicians and midwives. It is used to keep an eye on a pregnant woman's contractions and the heart rate of the unborn child. The baby's heart rate is measured using cardiotocography (CTG). Additionally, it keeps an eye on womb contractions at almost the same time (uterus). Antenatal CTG is used to examine the foetus for any signs of problems both before and during labour. Physicians and midwives can determine the baby's emotional state by examining numerous characteristics of the foetus heart rate.
To determine the baby's heart rate, CTG uses ultrasound, which uses sound waves. Unheard high-frequency sound called ultrasound can be put out (emitted) and picked up by specialised equipment. Fluids and soft tissues are both transparent to ultrasound. However, when ultrasound strikes a more solid surface, its 'echoes' back as a reflection. The mother's abdominal tension is measured by another plate on the CTG. This measurement can be used to detect uterine contractions.
COVID-19 Impact: Supply and Lockdown Limitation to Impede Market Advancement
The COVID-19 pandemic had a significant impact on markets, consumer behavior, economies, and society in a short period of time. With offices, educational institutions, and manufacturing facilities closing permanently, important sporting events being postponed, and work-from-home and social distance rules in place, businesses are increasingly looking for strategies to help them get through these challenging times. Supply chain breaches, stock market inefficiencies, and vendor instability are the results of these advances. These are continuously obstructing the cardiotocograph (CTG) market growth. Due to the pandemic, new market dynamics and digitalization have emerged, fostering the development of CTG models and strategies for regaining growth and revenue streams.
LATEST TRENDS
"Increasing Software Advancements to Increase Sales and Revenue"
Recent years have seen a dramatic increase in popularity of the CTG approach. Hopes are placed on considerable software advancements, particularly in the areas of artificial intelligence and SWARM technologies, which allow for the separation of relevant signals from complex signals, promoting the growth of the market. An ultrasound transducer is used by the equipment to identify and track the foetal heart rate. Artificial intelligence has proved to be a significant point in cardiotocograph (CTG) market. Due to their ability to automate certain tracking tasks, several CTG provide capabilities that are advantageous to physician and midwives. This can improve the accuracy and error-free nature of tracking any problem related to birth.
Cardiotocograph (CTG) Market SEGMENTATION
- Request a Free sample to learn more about this report
- By Type
Based on type; the market is divided into traditional CTG and intelligent CTG
Traditional CTG are the leading part of the type segment.
- By Application
Based on the application; the market is divided into hospital, clinical and home
Hospital is the leading part of the application segment.
DRIVING FACTORS
"Advancements in Identifiable Heart Rate Deceleration to Enhance Market Growth"
The cardiotocograph strategy has seen a sharp rise in popularity in recent years. Foetal decelerations are short-lived, observable drops in the foetal heart rate (FHR) that are discovered through electronic foetal heart monitoring. Through the use of a cardiotocograph, electronic foetal monitoring records the foetus heartbeat as well as the mother's uterine contractions both before and during delivery. Additionally, a cardiotocograph is utilised to track variations in the FHR standard that occur at a rate of at least two cycles per minute and with inconsistent amplitude and inconsistent frequency. These variations are visually measured as the peak to trough amplitude in beats/minute.
"Constant Observations Options to Enhances Industry Progress"
During labor and delivery, cardiotocograph are used by doctors, nurses, and midwives to monitor the baby. Cardiotocograph (CTG) provides an option of constant observation (CM) throughout the labour and keeps track of the baby's heartbeat. Therefore, fostering the growth of market of cardiotocograph (CTG). A baby's heart rate rises when the baby moves, usually around 120 and 160 beats / minute. An indirect technique to determine whether the baby is receiving adequate oxygenation from the placenta is to see if his heart rate changes in response to his movements. Additionally, the test will look at how contractions impact the baby's heart rate. The doctor keeps an eye on the infant's heartbeat during the test, first while he is sleeping and then when he is moving. The baby's heartbeat should increase while he is moving or kicking, just as it does when you are active. Cardiotocography is used in the healthcare sector to ensure the health of the mother and the unborn child.
RESTRAINING FACTORS
"High Costs and Maintenance to Hinder Market Advancement"
The treatment of pregnancy and labour, especially in the case of high-risk patients, has become impossible without electronic foetal monitoring, with a focus on cardiotocography (CTG). While this is a crucial component of the practice in high-income nations, many (LMICs) low- and medium-income countries lack the resources and expertise to use the technology in their centres. This is due to a number of factors, including inadequate training in the collecting and interpretation of traces, ignorance of the tool's importance, and excessive anxiety of rising maintenance and equipment costs, among others. Therefore, restraining the cardiotocograph (CTG) market from expansion.
Cardiotocograph (CTG) Market REGIONAL INSIGHTS
- Request a Free sample to learn more about this report
"Increased Industry Consumption to Promote Market Development in Asia Pacific"
Asia Pacific has the largest share of the worldwide cardiotocograph (CTG) market. The expansion of the area can be attributed to a rise in Asia Pacific consumer spending in sectors like healthcare and housing. Asia Pacific dominates the cardiotocograph (CTG) market due to rising birth rates and the healthcare industry. The market is projected to be driven by the rising trend of improvements in heart rate deceleration that can be easily identified as well as a rise in demand for choices for constant surveillance. It is anticipated that as technology advances in emerging countries, there will be a rise in the demand for machines. The existence of significant industry players in the region is predicted to enhance cardiotocograph (CTG) market share. The presence of multiple healthcare facilities and technological improvement in different countries are expected to drive the market share. To develop and increase the share in the market, maximum country contributions are anticipated.
KEY INDUSTRY PLAYERS
"Participants in the Industry to Promote Market Expansion"
The strategies used by market participants in recent years, had a substantial impact on the market's expansion of cardiotocograph (CTG). The study includes information and specifics about the businesses and how they engage with the market. Through suitable research, technological developments, expansions, and expanding machinery and equipment, the data is acquired and published. The companies who create and offer new products, the regions in which they operate, mechanisation, innovation methods, making the most money, and using their products to significantly impact society are other factors taken into account for this market.
List of Market Players Profiled
- GE Healthcare (U.S.)
- Philips Healthcare (U.S.)
- Edan Instruments (China)
- BIOLIGHT (China)
- ArjoHuntleigh (India)
- Contec Medical Systems (China)
- Sunray Medical Apparatus (China)
- Bionet (U.S.)
- Luckcome (China)
- Medgyn Products (U.S.)
- BRAEL-Medical Equipment (Poland)
- Medical ECONET (Germany)
REPORT COVERAGE
The report with the investigations that outline the market players with an impact on the anticipated time frame is examined in this study. It provides a complete examination as well as a detailed analysis by taking into account a variety of factors, including growth rate, trends, industrial advances, technologies, growth, distribution, and impediments. The analysis would need to be changed if the notable opponents or the projected assessment of market dynamics change. This study examined the consumption, manufacturing, annual growth, and share price of manufacturers in terms of production.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 330.6 Million in 2021 |
Market Size Value By |
US$ 537.83 Million by 2031 |
Growth Rate |
CAGR of 5.2% from 2021 to 2031 |
Forecast Period |
2024-2031 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Type and Application |
Frequently Asked Questions
-
What value is the cardiotocograph market expected to touch by 2031?
Based on our research, the global cardiotocograph (CTG) market is projected to touch USD 537.83 million by 2031.
-
What CAGR is the cardiotocograph market expected to exhibit by 2031?
The cardiotocograph market is expected to exhibit a CAGR of 5.0% by the forecasted year 2031.
-
What are the driving factors of the cardiotocograph market?
The cardiotocograph market for cardiotocographs (CTG) is expanding as a result of the growing use of these devices in the healthcare, clinical, home, and other sectors.
-
Which are the top companies operating in the cardiotocograph market?
GE Healthcare, Philips Healthcare, Edan Instruments BIOLIGHT, ArjoHuntleigh, Contec Medical Systems, Sunray Medical Apparatus, Bionet, Luckcome, Medgyn Products, BRAEL-Medical Equipment and Medical ECONET are the top companies operating in the cardiotocograph market.